A detailed history of Voloridge Investment Management, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 440,839 shares of VERA stock, worth $20.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
440,839
Previous 446,905 1.36%
Holding current value
$20.1 Million
Previous $19.3 Million 17.23%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$33.72 - $48.82 $204,545 - $296,142
-6,066 Reduced 1.36%
440,839 $15.9 Million
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $6.41 Million - $21.1 Million
430,144 Added 2566.34%
446,905 $19.3 Million
Q4 2023

Feb 14, 2024

SELL
$9.29 - $16.0 $491,533 - $846,560
-52,910 Reduced 75.94%
16,761 $257,000
Q3 2023

Nov 14, 2023

BUY
$13.71 - $19.64 $955,189 - $1.37 Million
69,671 New
69,671 $955,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.23B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.